US20050255582A1 - Surface modifying composition - Google Patents

Surface modifying composition Download PDF

Info

Publication number
US20050255582A1
US20050255582A1 US11/124,022 US12402205A US2005255582A1 US 20050255582 A1 US20050255582 A1 US 20050255582A1 US 12402205 A US12402205 A US 12402205A US 2005255582 A1 US2005255582 A1 US 2005255582A1
Authority
US
United States
Prior art keywords
formula
individually
group
moiety
alkanethiol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/124,022
Inventor
Milan Mrksich
Yan-Yeung Luk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Chicago
Arch Development Corp
Original Assignee
Arch Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arch Development Corp filed Critical Arch Development Corp
Priority to US11/124,022 priority Critical patent/US20050255582A1/en
Assigned to THE UNIVERSITY OF CHICAGO reassignment THE UNIVERSITY OF CHICAGO ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LUK, YAN-YEUNG, MRKSICH, MILAN
Publication of US20050255582A1 publication Critical patent/US20050255582A1/en
Assigned to NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT reassignment NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS). Assignors: UNIVERSITY OF CHICAGO
Abandoned legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00Processes for applying liquids or other fluent materials
    • B05D1/18Processes for applying liquids or other fluent materials performed by dipping
    • B05D1/185Processes for applying liquids or other fluent materials performed by dipping applying monomolecular layers

Definitions

  • the present invention relates to self-assembled monolayers (SAMs) of alkanethiolates.
  • SAMs of alkanethiolates on gold are an important class of model substrates for mechanistic studies of the interactions of proteins and cells with surfaces.
  • a primary reason for the importance of these model substrates is the availability of SAMs that are inert—that is, SAMs that prevent or inhibit the adsorption of protein and the attachment of cells.
  • This class of SAMs has been critical for developing methods to pattern the adhesion of cells, to prepare surfaces that present ligands for selective interactions with proteins, and to design electroactive dynamic substrates that can modulate the selective recognition of proteins.
  • the present invention is an alkanethiol of formula (1) and the enantimomers of the alkanethiol of formula (1): HS-L-Q-T (1), where -L- is -(A x -B y -E z -D) w -; each A, B, E and D are individually C(R A R A ′)—, —C(R B R B ′)—, —C(R E R E ′)—, and —C(R D R D ′)—, respectively; each R A , R B , R E and R D are individually H, or any two of R A , R B , R E and R D together form a bond, or R A , R B , R E and R D together with the atoms to which they are bonded form a six-membered aromatic ring; each R A ′, R B ′, R E ′ and R D ′ are individually H, or any two of R A ′, R B ′
  • the present invention is a disulfide of formula (3) and the enantimomers of the disulfide of formula (3): T-Q-L-S—S-J (3), where -L-, -Q-, and -T have the same meaning as above; -J is selected from the group consisting of H, halogen, R, —OR, —NRR′, —C(O)R, and —C(O)OR; R is selected from the group consisting of alkyl, alkenyl, alkynyl, aryl and heterocyclic radical; and R′ is selected from the group consisting of H, alkyl, alkenyl, alkynyl, aryl and heterocyclic radical.
  • the present invention is a substrate, includes (i) a surface layer comprising gold, and (ii) a plurality of moieties, on at least a portion of the surface layer, where the moieties are alkanethiolate moieties of formula (5) and enantimomers of the alkanethiolate moieties of formula (5): Surf-S-L-Q-T (5); -L-, -Q-, and -T have the same meaning as above; and Surf designates where the moiety attaches to the surface.
  • the present invention is a substrate, including (i) a surface layer comprising gold, and (ii) a monolayer comprising moieties, on at least a portion of the surface layer, where the moieties are alkanethiolate moieties; and the monolayer does not fail a cell patterning test at 25 days.
  • the present invention is a cell chip, including a substrate described above, and cells on the substrate.
  • the present invention is a protein chip, including a substrate described above, and protein on the substrate.
  • Alkyl refers to a substituted or unsubstituted, straight, branched or cyclic hydrocarbon chain, preferably containing from 1 to 20 carbon atoms. More preferred alkyl groups are alkyl groups containing from 7 to 16 carbon atoms. Preferred cycloalkyls have from 3 to 10, preferably 3-6, carbon atoms in their ring structure.
  • Suitable examples of unsubstituted alkyl groups include methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, iso-butyl, tert-butyl, sec-butyl, cyclobutyl, pentyl, cyclopentyl, hexyl, cyclohexyl, and the like.
  • Alkylaryl and “alkylheterocyclic” groups are alkyl groups covalently bonded to an aryl or heterocyclic group, respectively.
  • Alkenyl refers to a substituted or unsubstituted, straight, branched or cyclic, unsaturated hydrocarbon chain that contains at least one double bond, and preferably 2 to 20, more preferably 7 to 16, carbon atoms.
  • exemplary unsubstituted alkenyl groups include ethenyl (or vinyl)(—CH ⁇ CH 2 ), 1-propenyl, 2-propenyl (or allyl)(—CH 2 —CH ⁇ CH 2 ), 1,3-butadienyl (—CH ⁇ CHCH ⁇ CH 2 ), 1-butenyl (—CH ⁇ CHCH 2 CH 3 ), hexenyl, pentenyl, 1,3,5-hexatrienyl, and the like.
  • Preferred cycloalkenyl groups contain five to eight carbon atoms and at least one double bond.
  • Examples of cycloalkenyl groups include cyclohexadienyl, cyclohexenyl, cyclopentenyl, cycloheptenyl, cyclooctenyl, cyclohexadienyl, cycloheptadienyl, cyclooctatrienyl and the like.
  • Alkynyl refers to a substituted or unsubstituted, straight, branched or cyclic unsaturated hydrocarbon chain containing at least one triple bond, and preferably 2 to 20, more preferably 7 to 16, carbon atoms.
  • Aryl refers to any monovalent aromatic carbocyclic or heteroaromatic group, preferably of 3 to 10 carbon atoms.
  • the aryl group can be monocyclic (i.e. phenyl (or Ph)) or polycyclic (i.e. naphthyl) and can be unsubstituted or substituted.
  • Preferred aryl groups include phenyl, naphthyl, furyl, thienyl, pyridyl, indolyl, quinolinyl or isoquinolinyl.
  • Halogen refers to fluorine, chlorine, iodine or bromine.
  • the preferred halogen is fluorine or chlorine.
  • Heterocyclic radical refers to a stable, saturated, partially unsaturated, or aromatic ring, preferably containing 5 to 10, more preferably 5 or 6, atoms.
  • the ring can be substituted 1 or more times (preferably 1, 2, 3, 4 or 5 times) with a substituent.
  • the ring can be mono-, bi- or polycyclic.
  • the heterocyclic group consists of carbon atoms and from 1 to 3 heteroatoms independently selected from the group consisting of nitrogen, oxygen, and sulfur. The heteroatoms can be protected or unprotected.
  • heterocyclic groups include substituted or unsubstituted, protected or unprotected acridine, benzathiazoline, benzimidazole, benzofuran, benzothiophene, benzothiazole, benzothiophenyl, carbazole, cinnoline, furan, imidazole, 1H-indazole, indole, isoindole, isoquinoline, isothiazole, morpholine, oxazole (i.e.
  • 1,2,3-oxadiazole phenazine, phenothiazine, phenoxazine, phthalazine, piperazine, pteridine, purine, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, quinazoline, quinoline, quinoxaline, thiazole, 1,3,4-thiadiazole, thiophene, 1,3,5-triazines, triazole (i.e. 1,2,3-triazole), and the like.
  • “Substituted” means that the moiety contains at least one, preferably 1-3 substituent(s). Suitable substituents include hydrogen (H) and hydroxyl (—OH), amino (—NH 2 ), oxy (—O—), carbonyl (—CO—), thiol, alkyl, alkenyl, alkynyl, alkoxy, halo, nitrile, nitro, aryl and heterocyclic groups. These substituents can optionally be further substituted with 1-3 substituents.
  • substituted substituents include carboxamide, alkylmercapto, alkylsulphonyl, alkylamino, dialkylamino, carboxylate, alkoxycarbonyl, alkylaryl, aralkyl, alkylheterocyclic, and the like.
  • “Disulfide” means a compound containing a bond between two sulfur atoms.
  • Alkanethiol means a compound containing an alkyl group bonded to an SH group.
  • Alkanethiolate means a moiety corresponding to an alkanethiol without the hydrogen of the SH group.
  • Alkylene refers to a substituted or unsubstituted, straight, branched or cyclic hydrocarbon chain, preferably containing from 1 to 20 carbon atoms. More preferred alkylene groups are lower alkylene groups, i.e., alkylene groups containing from 1 to 6 carbon atoms. Preferred cycloalkylenes have from 3 to 10, preferably 3-6, carbon atoms in their ring structure. Suitable examples of unsubstituted alkylene groups include methylene, —(CH 2 ) n —, —CH 2 —CH(CH 3 )—, —(C 6 H 10 )— where the carbon atoms form a six-membered ring, and the like.
  • FIG. 1 illustrates data from surface plasmon resonance spectroscopy for the adsorption of fibrinogen to each of four SAMs, showing the relative change in angle of minimum reflectivity as sloutions are flowed over the SAMs. The curves are offset vertically for clarity.
  • FIG. 2 is optical micrographs for cells patterned into circular regions of HDT surrounded by regions of other SAMs.
  • FIG. 3 illustrates a patterned substrate
  • FIG. 4 illustrates another patterned substrate.
  • the present invention includes new alkanethiols and disulfides, and SAMs prepared from these compounds that are inert surfaces.
  • the SAMs exhibit excellent inertness to both protein adhesion and cell attachment, demonstrating their usefulness to prepare protein and cell chips.
  • the alkanethiols have the structure shown in formula (1) and the enantimomers of the structure shown in formula (1): HS-L-Q-T (1) where -L- is -(A x -B y -E z -D) w -; each A, B, E and D are individually C(R A R A ′)—, —C(R B R B ′)—, —C(R E R E ′)—, and —C(R D R D ′)—, respectively; each R A , RB, R E and R D are individually H, or any two of R A , R B , R E and RD together form a bond, or R A , R B , R E and R D together with the atoms to which they are bonded form a six-membered aromatic ring; each R A ′, R B ′, R E ′ and R D ′ are individually H, or any two of R A ′, R B ′, R E ′
  • the disulfides have the structure shown in formula (3) and the enantimomers of the structure shown in formula (3): T-Q-L-S—S-J (3) where -L-, -Q- and -T have the same meaning as in formula (1), and -J is selected from the group consisting of H, halogen, R, —OR, —NRR′, —C(O)R, and —C(O)OR; R is selected from the group consisting of alkyl, alkenyl, alkynyl, aryl and heterocyclic radical; R′ is selected from the group consisting of H, alkyl, alkenyl, alkynyl, aryl and heterocyclic radical.
  • -L- contains 6 to 20 carbon atoms, more preferably 8 to 18 carbon atoms.
  • -L- contains 1 or 0 double bonds, or 1 triple bond.
  • -L- is an alkylene containing 6 to 18 carbon atoms.
  • -Q- is —O— or —CH 2 —.
  • -T is a moiety of formula (2′)
  • a is 1, b is 1 and at least one of R 1 and R 2 is OH.
  • -J is a moiety of formula (4) L′-Q′-T′ (4), an alkyl having 1 to 4 carbon atoms, or is —(CH 2 ) c (OCH 2 CH 2 ) n OH; where -L′-, -Q′-, and -T′ have the same meaning as -L-, -Q-, and -T respectively, c is 2 to 20, and n is 1 to 3.
  • -J is moiety of formula (4′): -L-Q-T (4′).
  • alkanethiols and disulfides of the present invention may be synthesized using reagents and reaction well known to those of ordinary skill in the art, such as those described in “Advanced Organic Chemistry” J. March (Wiley & Sons, 1994); and “Organic Chemistry” 4th ed., Morrison and Boyd (Allyn and Bacon, Inc., 1983).
  • reaction scheme may be used:
  • alkanethiols of formula (1) where -Q- is —CH 2 — the OH may be converted to a tosylate or mesylate, and Br converted to the corresponding Grignard.
  • -Q- is —CO—O—
  • Br in the above reaction scheme may be replaced with CO 2 H.
  • Br in the above reaction scheme may be replaced with OH, and the OH may be converted to the corresponding acid.
  • alkanethiols of formula (1) where -Q- is —NH—CO— Br in the above reaction scheme may be replaced with NH 2 , and the OH may be converted to the corresponding acid.
  • Br in the above reaction scheme may be replaced with CO 2 H, and the OH may be converted to the corresponding primary amine (for example, by tosylation or mesylation followed by reaction with ammonia).
  • -Q- is —NH—CO—NH—
  • Br in the above reaction scheme may be replaced with NH 2 , and the OH may be converted to the corresponding isocyanate.
  • alkanethiols of formula (1) where -Q- is —NH—CO—O— Br in the above reaction scheme may be replaced with —N ⁇ C ⁇ O to give an isocyanate, which is then reacted with the hydroxyl as shown.
  • the disulfides may be formed by first forming alkanethiols, followed by oxidative coupling. When the disulfide is not symmetric, two different alkanethiols are oxidized together.
  • the surface preferably has a plurality of alkanethiolate moieties shown in formula (5) Surf-S-L-Q-T (5) where -L-, -Q- and -T have the same meaning as in formula (1), and Surf designates where the moiety attaches to the surface.
  • the density of moieties on the surface is typically 10 10 ⁇ 5% per square centimeter.
  • the moieties of the present invention may cover the entire surface, or may be patterned on the surface. Patterning may be carried out by, for example, by microprinting, as described in Mrksich, M.; Dike, L. E.; Tien, J.; Ingber, D. E.; Whitesides, G. M., Experimental Cell Research 1997 235, 305-313; Chen, C. S.; Mrksich, M.; Huang, S.; Whitesides, G. M.; Ingber, D. E., Science 1997, 276, 1425-1428; and Mrksich, M.; Whitesides, G. M., TIBTECH. 1995, 13, 228-235.
  • the surface contains gold, more preferably the surface contains 50 to 100 atom percent gold.
  • the surface is pure or fine gold, or an alloy of gold with copper, silver, or a combination thereof.
  • the surface may be on a base.
  • the base may have the same composition as the surface (for example a gold surface on a gold plate), or the surface may be, for example, a film, foil, sheet, or plate, on a base having a different composition.
  • the base may be any material, such as metal, ceramic, plastic, or a natural material such as wood. Examples of bases include glass, quartz, silicon, transparent plastic, aluminum, carbon, polyethylene and polypropylene.
  • the surface material may be attached to the base by any of a variety of methods.
  • a film of the surface material may be applied to the base by sputtering or evaporation. If the surface material is a foil or sheet, in could be attached with an adhesive.
  • the surface need not completely cover the base, but may cover only a portion of the base, or may form a pattern on the base. For example, portions of the base could be patterned by sputtering the base, covering those portions of the base where no surface material is desired. These patterns may include an array of regions containing, or missing, the surface material.
  • a cell chip is an array of regions containing cells on a surface, separated by regions containing no cells or cells at a much lower density. Since the SAMs of the present invention are inert, it is difficult for cells to attach.
  • a cell chip may be prepared by applying SAMs of the present invention on regions of the surface that are to remain free of cells (or is intended to have cells at a lower density). The remaining regions could be left uncovered, or could be cover with SAMs that are not inert.
  • FIG. 3 illustrates one possible pattern, where circles 10 contain a SAM of hexadecanethiolate, and the remainder 20 of the surface is covered with a SAM of the present invention, all on a surface 2 .
  • FIG. 4 illustrates another possible pattern, where squares 30 contain a SAM of hexadecanethiolate, and regions 40 surrounding the squares contain a SAM of the present invention, all on a surface 2 .
  • the cells may be allowed to attach and proliferate in the regions not containing SAMs of the present invention, by contacting those regions with cells, and providing the nutrients and conditions necessary for the cells to proliferate.
  • a cell pattern test is carried out as follows: A surface is patterned into hydrophobic regions of hexadecanethiolate (HDT) and surrounded by the inert monolayer to be tested. The pattern is formed by microprinting.
  • Albino 3T3-Swiss fibroblasts (American Type Culture Collection) are harvested from culture dishes with trypsin-EDTA, washed, and resuspended in DMEM (Dulbecco's Modification of Eagle's Medium) supplemented with 10% fetal bovine serum. The suspended cells are added to wells (10,000/well) containing patterned surfaces immersed in DMEM supplemented with serum.
  • Serum-supplemented medium is exchanged with fresh medium after 12 hours and then every 5 days.
  • Cell cultures are maintained at 37° C. and photographed daily.
  • the test is failed.
  • SAMs of the present invention do not fail the cell patterning test at 12 days, more preferably at 14 days, even more preferably at 25 days.
  • a protein chip is an array of regions containing protein, separated by regions containing no protein or protein at a much lower density. Since the SAMs of the present invention are inert, it is difficult for proteins to attach.
  • a protein chip may be prepared by applying SAMs of the present invention on regions of the surface that are to remain free of protein (or intended to have protein at a lower density). The remaining regions could be left uncovered, or could be cover with SAMs that are not inert.
  • the same variety of patterns is possible with protein chips as described above for cell chips; FIGS. 3 and 4 are two possible patterns.
  • the protein chip may then be prepared by contacting the surface with the desired protein or proteins.
  • a protein chip may be formed by covering both regions of the surface that are intended to have protein, and those that are not intended to have protein, with SAMs of the present invention. Those regions that are intended to have protein will also include an alkanethiolate corresponding to an alkanethiol terminated in a specific moiety.
  • the protein to be attached is chosen to include a region that will capture the specific moiety, anchoring the protein to the chosen regions.
  • the specific moiety may be the conjugate of glutathione and benzoquinone of formula (6) and the protein may be a fusion protein of a protein of interest (such as the peptide hemagglutinin (HA) and glutathione S-transferase (GST) (the fusion protein being designated as GST-HA).
  • HA peptide hemagglutinin
  • GST glutathione S-transferase
  • the protein is cross-linked to the alkanethiolate, anchoring the protein in place. Since the SAM mostly contains the inert moiety of the present invention, other undesired proteins do not attach to the surface.
  • GST is commonly used as an affinity handle for the purification of recombinant proteins; the protein is expressed and purified as the GST fusion protein, and then treated with a protease to remove the GST domain (see, for example, Smith, D. B.; Johnson, K. S. Gene 1988, 67, 31). These fusion proteins could be used without synthetic modification to form protein chips.
  • An additional benefit of using GST fusion proteins together with SAMs formed from alkanethiols terminated with the conjugate of formula (6) is that the reactivity of the surface towards immobilization could be controlled electrochemically, by way of reversible reduction of the quinone of formula (6) to the unreactive hydroquinone.
  • SPR Surface plasmon resonance
  • Gold films were prepared by evaporation of titanium (1.5 nm) and then gold (40 nm) onto glass cover slips (0.20 mm, No. 2, Corning).
  • the SAMs were prepared by immersing gold films of approximately 1 cm 2 in ethanolic solutions of alkanethiol (2 mM) for 9 hours. The SAMs were rinsed with ethanol and dried with nitrogen before use.
  • a control monolayer that is not inert a SAM of hexadecanethiolate that presents hydrophobic methyl groups at the surface were used.
  • Monolayers terminated in the tri(ethylene glycol) group were used as the current standard for inert surfaces.
  • Each of the two additional monolayers presents the mannitol group and differs only in the length of alkyl chain to which the mannitol group is appended.
  • Alkanethiol 1a has an alkyl chain of eleven methylene units, which is the standard length in SAMs that are used in bio-interfacial science.
  • Alkanethiol 1b has three fewer methylene units in the alkyl chain.
  • Alkanethiol 2 terminates in the tri(ethylene glycol) group.
  • Alkanethiol 1a The mannitol-terminated alkanethiol 1a was synthesized with the same protocol starting with 1′-bromo-1-undecene in place of 8-bromo-1-octene.
  • SPR was used to measure the adsorption of five proteins—fibrinogen, pepsin, lysozyme, insulin, and trypsin—to the four monolayers.
  • SPR measures changes in the refractive index of a solution near the interface with a gold film by measuring changes in the angle ( ⁇ m ) at which p-polarized light reflected from the glass/gold interface has a minimum in intensity.
  • SAMs were mounted in a flow cell and experiments were performed by first flowing a phosphate buffered saline (PBS) through the cell for 5 minutes, then a solution of protein in the same buffer (0.5 mg/ml) for 5 minutes, and then PBS for 5 minutes. The rise in ⁇ m upon introduction of the protein solution has two contributions.
  • PBS phosphate buffered saline
  • the first is due to the increase in refractive index of the solution caused by the dissolved protein—the “bulk effect”—and does not represent protein adsorption.
  • the second contribution is due to the adsorption of protein to the SAM.
  • the amount of protein that adsorbs irreversibly to the SAM is determined by comparing the shift in ⁇ m before and after the SAM is exposed to protein.
  • An increase in ⁇ m of 0.1° corresponds to an increase in density of adsorbed protein of 1 ng/mm 2 .
  • FIG. 1 shows data for the adsorption of fibrinogen to the four SAMs.
  • a complete monolayer of protein adsorbs to the SAM of hexadecanethiolate.
  • the change in ⁇ m of 0.35° corresponds to a density of protein of 3,500 pg/mm 2 .
  • the two monolayers presenting mannitol groups show essentially no adsorption of fibrinogen. This lack of adsorption is indistinguishable from that on monolayers presenting tri(ethylene glycol) groups.
  • Experiments with the four other proteins gave similar results and demonstrated that the mannitol group is broadly effective at preventing protein adsorption, as shown in Table 1.
  • Gold films were patterned by microcontact printing a set of circular regions of hexadecanethiolate that were 200 ⁇ m in diameter and then the films were immersed in a solution of 1a, 1b or 2 to assemble an inert monolayer on the non-printed areas.
  • Albino 3T3-Swiss fibroblasts (American Type Culture Collection) were harvested from culture dishes with trypsin-EDTA, washed, and resuspended in DMEM supplemented with 10% fetal bovine serum.
  • the suspended cells were added to wells (10,000/well) containing patterned substrates immersed in DMEM supplemented with serum. Serum-supplemented medium was exchanged with fresh medium after 12 hours and then every 5 days. Cell cultures were maintained at 37° C. and photographed daily. When the suspension of cells was added to culture wells containing the substrates, cells attached only to the methyl-terminated regions. For each of the substrates patterned with the inert monolayers (1a, 1b and 2), cells spread and proliferated to completely occupy these regions but did not invade the surrounding inert regions. The period of time that cells remain confined to the patterned monolayers provides a relative measure of the effectiveness of inert surface chemistries, and a direct measure for identifying inert surfaces that are most effective for applications requiring long-term cell patterning.
  • Albino 3T3-Swiss fibroblast cells patterned on the monolayers were kept at 37° C. in serum-containing media for four weeks. The media was exchanged every five days and cells were photographed daily, as shown in FIG. 2 . In all cases, cells remained patterned to the circular regions of hexadecanethiolate for at least six days in culture.
  • the tri(ethylene glycol)-terminated (prepared from alkanethiol 2) monolayers began to fail after seven days, with cells spreading onto the inert regions. After 12 days, cells had migrated from the circular regions and divided to give a confluent monolayer of cells, with a complete loss of pattern.
  • Monolayers terminated in the mannitol group were substantially more effective at confining cells for longer periods. Even after 21 days, cells remained completely confined to the patterns. After 25 days in culture, the viability of the adherent cells decreased, and therefore prevented an assessment of the monolayer over longer periods of time. Monolayers that presented the mannitol group on the shorter polymethylene chain (prepared from alkanethiol 1b) were also more effective than monolayers presenting the tri(ethylene glycol) group, but were not as effective as monolayers of 1a. Monolayers of 1b generally failed at two weeks in culture. These long-term patterning experiments were repeated on three separate occasions with consistent results: monolayers of 2 fail at approximately one week, monolayers of 1b fail at approximately two weeks and monolayers of 1a are effective for at least three weeks.
  • the SAMs 1a and 1b are highly effective as inert surfaces. SPR showed that monolayers of 1a and 1b prevented the adsorption of several different proteins, including the “sticky” protein fibrinogen. In this respect, the monolayers were indistinguishable from monolayers presenting tri(ethylene glycol) groups, which are the current standard for inert model surfaces. When evaluated for the ability to maintain the patterned adhesion of cells, it was found that SAMs of 1a were superior to SAMs presenting tri(ethylene glycol) groups. In this and other work, it has been found that SAMs presenting tri(ethylene glycol) groups fail at approximately seven days in culture. The SAMs of the present invention, by contrast, maintained the pattern of adherent cells over as many as 25 days.
  • alkanethiol (Z) A reaction scheme to prepare an alkanethiol terminated in a moiety that will cross-link to a glutathione S-transferase fusion protein (alkanethiol (Z)) is described below.
  • hydroquinone was protected as the bis-tetrahydropyranyl ether, which was then deprotonated with tert-butyl lithium and alkylated with 1,4-dibromobutane.
  • molecule (Y) was prepared by protecting the tri(ethylene glycol)-terminated alkanethiol as the tritylthioether. The free hydroxyl group of this molecule was alkylated with (X) to give the conjugate.
  • a monolayer was prepared from a mixture of alkanethiol (Z) and a alkanethiol 1a (in a ratio of 1:99).
  • the surface was treated to oxidize the hydroquinone group of alkanethiol (Z) to the corresponding benzoquinone, either by applied electrical potentials (+500 mV for 1 minute), or by treatment with a chemical oxidant (for example, with a substituted quinone).
  • SPR Surface plasmon resonance
  • the SAMs of the present invention are significant because they extend the time course over which cells can be patterned in culture. This enhancement is important for several applications that use cells as functional components. A primary example is the use of genetically engineered cells for screening libraries of drug candidates. This and other applications require substrates that can maintain patterned cell populations with excellent fidelity and over long periods of time. Furthermore, the SAMs of the present invention are highly effective at preventing protein adsorption and extend the times over which cultured cells can be maintained in patterns.

Abstract

Alkanethiols of formula (1) and the enantimomers of the alkanethiol of formula (1):
HS-L-Q-T  (1), and disulfides of formula (3) and the enantimomers of the disulfide of formula (3):
T-Q-L-S—S-J  (3),
where -T is a moiety of formula (2)
Figure US20050255582A1-20051117-C00001

R1 and R2 are each individually selected from the group consisting of H and OH; a is 0 to 3; b is 0 to 3; and

Description

  • This application is a continuation of U.S. patent application Ser. No. 09/689,263, filed on Oct. 11, 2000.
  • FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
  • The subject matter of this application was in part funded by the DARPA and the NIH (Grant no. OM-R29-54621-04). The government may have certain rights in this invention.
  • BACKGROUND
  • The present invention relates to self-assembled monolayers (SAMs) of alkanethiolates.
  • SAMs of alkanethiolates on gold are an important class of model substrates for mechanistic studies of the interactions of proteins and cells with surfaces. A primary reason for the importance of these model substrates is the availability of SAMs that are inert—that is, SAMs that prevent or inhibit the adsorption of protein and the attachment of cells. Monolayers terminated in short oligomers of the ethylene glycol group ([OCH2CH2]nOH, n=3-6) are known to prevent the adsorption of virtually all proteins under a wide range of conditions. This class of SAMs has been critical for developing methods to pattern the adhesion of cells, to prepare surfaces that present ligands for selective interactions with proteins, and to design electroactive dynamic substrates that can modulate the selective recognition of proteins.
  • Given the importance of inert surfaces, it is surprising that there are so few functional groups that have been identified that render materials inert—and none that are as effective at preventing protein adsorption as are oligo(ethylene glycol) groups when presented on SAMs. A monolayer presenting a tri(propylene sulfoxide) group was reported as inert to protein adsorption and cell attachment. While monolayers terminated in this propylene sulfoxide group prevented protein adsorption, they were generally less effective and less stable over time than were SAMs presenting oligo(ethylene glycol) groups. The synthetic route to the propylene sulfoxide oligomers is laborious, which further limits the utility of these monolayers. Another example, a monolayer terminated in the carbohydrate maltose, was reported to prevent protein adsorption. In that work, the lack of adsorption was demonstrated with ellipsometric measurements, which required the substrate be removed from solution, rinsed and then dried prior to the measurement. Because this and related ex situ techniques cannot detect weak and reversible adsorption, it is not clear whether these monolayers will ultimately prove inert in settings where the substrate is in contact with a protein-containing solution for long periods of time.
  • The development or identification of alternative functional groups that can render SAMs inert to protein adsorption and cell attachment is important, since it is probable that no one surface chemistry will be best suited to give an inert interface under all conditions. The availability of several inert surface chemistries would permit optimization of the substrate properties for each unique application.
  • BRIEF SUMMARY
  • In a first aspect, the present invention is an alkanethiol of formula (1) and the enantimomers of the alkanethiol of formula (1):
    HS-L-Q-T  (1),
    where -L- is -(Ax-By-Ez-D)w-; each A, B, E and D are individually C(RARA′)—, —C(RBRB′)—, —C(RERE′)—, and —C(RDRD′)—, respectively; each RA, RB, RE and RD are individually H, or any two of RA, RB, RE and RD together form a bond, or RA, RB, RE and RD together with the atoms to which they are bonded form a six-membered aromatic ring; each RA′, RB′, RE′ and RD′ are individually H, or any two of RA′, RB′, RE′ and RD′ together form a bond, or RA′, RB′, RE′ and RD′ together with the atoms to which they are bonded form a six-membered aromatic ring; each x, y and z are individually either 0 or 1; w is 1 to 5; -Q- is selected from the group consisting of
    Figure US20050255582A1-20051117-C00002

    -T is a moiety of formula (2)
    Figure US20050255582A1-20051117-C00003

    R1 and R2 are each individually selected from the group consisting of H and OH; a is 0 to 3; b is 0 to 3;
    Figure US20050255582A1-20051117-P00900
    and indicates that the chirality of the carbon atom to which it is attached is either R or S.
  • In a second aspect, the present invention is a disulfide of formula (3) and the enantimomers of the disulfide of formula (3):
    T-Q-L-S—S-J  (3),
    where -L-, -Q-, and -T have the same meaning as above; -J is selected from the group consisting of H, halogen, R, —OR, —NRR′, —C(O)R, and —C(O)OR; R is selected from the group consisting of alkyl, alkenyl, alkynyl, aryl and heterocyclic radical; and R′ is selected from the group consisting of H, alkyl, alkenyl, alkynyl, aryl and heterocyclic radical.
  • In a third aspect, the present invention is a substrate, includes (i) a surface layer comprising gold, and (ii) a plurality of moieties, on at least a portion of the surface layer, where the moieties are alkanethiolate moieties of formula (5) and enantimomers of the alkanethiolate moieties of formula (5):
    Surf-S-L-Q-T  (5);
    -L-, -Q-, and -T have the same meaning as above; and Surf designates where the moiety attaches to the surface.
  • In a fourth aspect, the present invention is a substrate, including (i) a surface layer comprising gold, and (ii) a monolayer comprising moieties, on at least a portion of the surface layer, where the moieties are alkanethiolate moieties; and the monolayer does not fail a cell patterning test at 25 days.
  • In a fifth aspect, the present invention is a cell chip, including a substrate described above, and cells on the substrate.
  • In a sixth aspect, the present invention is a protein chip, including a substrate described above, and protein on the substrate.
  • Definitions
  • “Alkyl” (or alkyl- or alk-) refers to a substituted or unsubstituted, straight, branched or cyclic hydrocarbon chain, preferably containing from 1 to 20 carbon atoms. More preferred alkyl groups are alkyl groups containing from 7 to 16 carbon atoms. Preferred cycloalkyls have from 3 to 10, preferably 3-6, carbon atoms in their ring structure. Suitable examples of unsubstituted alkyl groups include methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, iso-butyl, tert-butyl, sec-butyl, cyclobutyl, pentyl, cyclopentyl, hexyl, cyclohexyl, and the like. “Alkylaryl” and “alkylheterocyclic” groups are alkyl groups covalently bonded to an aryl or heterocyclic group, respectively.
  • “Alkenyl” refers to a substituted or unsubstituted, straight, branched or cyclic, unsaturated hydrocarbon chain that contains at least one double bond, and preferably 2 to 20, more preferably 7 to 16, carbon atoms. Exemplary unsubstituted alkenyl groups include ethenyl (or vinyl)(—CH═CH2), 1-propenyl, 2-propenyl (or allyl)(—CH2—CH═CH2), 1,3-butadienyl (—CH═CHCH═CH2), 1-butenyl (—CH═CHCH2CH3), hexenyl, pentenyl, 1,3,5-hexatrienyl, and the like. Preferred cycloalkenyl groups contain five to eight carbon atoms and at least one double bond. Examples of cycloalkenyl groups include cyclohexadienyl, cyclohexenyl, cyclopentenyl, cycloheptenyl, cyclooctenyl, cyclohexadienyl, cycloheptadienyl, cyclooctatrienyl and the like.
  • “Alkynyl” refers to a substituted or unsubstituted, straight, branched or cyclic unsaturated hydrocarbon chain containing at least one triple bond, and preferably 2 to 20, more preferably 7 to 16, carbon atoms.
  • “Aryl” refers to any monovalent aromatic carbocyclic or heteroaromatic group, preferably of 3 to 10 carbon atoms. The aryl group can be monocyclic (i.e. phenyl (or Ph)) or polycyclic (i.e. naphthyl) and can be unsubstituted or substituted. Preferred aryl groups include phenyl, naphthyl, furyl, thienyl, pyridyl, indolyl, quinolinyl or isoquinolinyl.
  • “Halogen” (or halo-) refers to fluorine, chlorine, iodine or bromine. The preferred halogen is fluorine or chlorine.
  • “Heterocyclic radical” refers to a stable, saturated, partially unsaturated, or aromatic ring, preferably containing 5 to 10, more preferably 5 or 6, atoms. The ring can be substituted 1 or more times (preferably 1, 2, 3, 4 or 5 times) with a substituent. The ring can be mono-, bi- or polycyclic. The heterocyclic group consists of carbon atoms and from 1 to 3 heteroatoms independently selected from the group consisting of nitrogen, oxygen, and sulfur. The heteroatoms can be protected or unprotected. Examples of useful heterocyclic groups include substituted or unsubstituted, protected or unprotected acridine, benzathiazoline, benzimidazole, benzofuran, benzothiophene, benzothiazole, benzothiophenyl, carbazole, cinnoline, furan, imidazole, 1H-indazole, indole, isoindole, isoquinoline, isothiazole, morpholine, oxazole (i.e. 1,2,3-oxadiazole), phenazine, phenothiazine, phenoxazine, phthalazine, piperazine, pteridine, purine, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, quinazoline, quinoline, quinoxaline, thiazole, 1,3,4-thiadiazole, thiophene, 1,3,5-triazines, triazole (i.e. 1,2,3-triazole), and the like.
  • “Substituted” means that the moiety contains at least one, preferably 1-3 substituent(s). Suitable substituents include hydrogen (H) and hydroxyl (—OH), amino (—NH2), oxy (—O—), carbonyl (—CO—), thiol, alkyl, alkenyl, alkynyl, alkoxy, halo, nitrile, nitro, aryl and heterocyclic groups. These substituents can optionally be further substituted with 1-3 substituents. Examples of substituted substituents include carboxamide, alkylmercapto, alkylsulphonyl, alkylamino, dialkylamino, carboxylate, alkoxycarbonyl, alkylaryl, aralkyl, alkylheterocyclic, and the like.
  • “Disulfide” means a compound containing a bond between two sulfur atoms.
  • “Alkanethiol” means a compound containing an alkyl group bonded to an SH group.
  • “Alkanethiolate” means a moiety corresponding to an alkanethiol without the hydrogen of the SH group.
  • “Alkylene” refers to a substituted or unsubstituted, straight, branched or cyclic hydrocarbon chain, preferably containing from 1 to 20 carbon atoms. More preferred alkylene groups are lower alkylene groups, i.e., alkylene groups containing from 1 to 6 carbon atoms. Preferred cycloalkylenes have from 3 to 10, preferably 3-6, carbon atoms in their ring structure. Suitable examples of unsubstituted alkylene groups include methylene, —(CH2)n—, —CH2—CH(CH3)—, —(C6H10)— where the carbon atoms form a six-membered ring, and the like.
  • All other acronyms and abbreviations have the corresponding meaning as published in journals relative to the art of chemistry.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Various other objects, features and attendant advantages of the present invention will be more fully appreciated as the same becomes better understood from the following detailed description when considered in connection with the accompanying drawings in which like reference characters designate like or corresponding parts throughout the several views and wherein:
  • FIG. 1 illustrates data from surface plasmon resonance spectroscopy for the adsorption of fibrinogen to each of four SAMs, showing the relative change in angle of minimum reflectivity as sloutions are flowed over the SAMs. The curves are offset vertically for clarity.
  • FIG. 2 is optical micrographs for cells patterned into circular regions of HDT surrounded by regions of other SAMs.
  • FIG. 3 illustrates a patterned substrate.
  • FIG. 4 illustrates another patterned substrate.
  • DETAILED DESCRIPTION
  • The present invention includes new alkanethiols and disulfides, and SAMs prepared from these compounds that are inert surfaces. The SAMs exhibit excellent inertness to both protein adhesion and cell attachment, demonstrating their usefulness to prepare protein and cell chips.
  • The alkanethiols have the structure shown in formula (1) and the enantimomers of the structure shown in formula (1):
    HS-L-Q-T  (1)
    where -L- is -(Ax-By-Ez-D)w-; each A, B, E and D are individually C(RARA′)—, —C(RBRB′)—, —C(RERE′)—, and —C(RDRD′)—, respectively; each RA, RB, RE and RD are individually H, or any two of RA, RB, RE and RD together form a bond, or RA, RB, RE and RD together with the atoms to which they are bonded form a six-membered aromatic ring; each RA′, RB′, RE′ and RD′ are individually H, or any two of RA′, RB′, RE′ and RD′ together form a bond, or RA′, RB′, RE′ and RD′ together with the atoms to which they are bonded form a six-membered aromatic ring; each x, y and z are individually either 0 or 1; and w is 1 to 5;
      • -Q- is selected from the group consisting of
        Figure US20050255582A1-20051117-C00004
      • -T is a moiety of formula (2)
        Figure US20050255582A1-20051117-C00005

        where R1 and R2 are each individually selected from the group consisting of H and OH; a is 0 to 3; b is 0 to 3;
        Figure US20050255582A1-20051117-P00900
        and indicates that the chirality of the carbon atom to which it is attached may be either R or S.
  • The disulfides have the structure shown in formula (3) and the enantimomers of the structure shown in formula (3):
    T-Q-L-S—S-J  (3)
    where -L-, -Q- and -T have the same meaning as in formula (1), and -J is selected from the group consisting of H, halogen, R, —OR, —NRR′, —C(O)R, and —C(O)OR; R is selected from the group consisting of alkyl, alkenyl, alkynyl, aryl and heterocyclic radical; R′ is selected from the group consisting of H, alkyl, alkenyl, alkynyl, aryl and heterocyclic radical.
  • Preferably, -L- contains 6 to 20 carbon atoms, more preferably 8 to 18 carbon atoms. Preferably, -L- contains 1 or 0 double bonds, or 1 triple bond. Most preferably, -L- is an alkylene containing 6 to 18 carbon atoms.
  • Preferably, -Q- is —O— or —CH2—.
  • Preferably, -T is a moiety of formula (2′)
    Figure US20050255582A1-20051117-C00006
  • Most preferably a is 1, b is 1 and at least one of R1 and R2 is OH.
  • Preferably, -J is a moiety of formula (4)
    L′-Q′-T′  (4),
    an alkyl having 1 to 4 carbon atoms, or is —(CH2)c(OCH2CH2)nOH; where -L′-, -Q′-, and -T′ have the same meaning as -L-, -Q-, and -T respectively, c is 2 to 20, and n is 1 to 3. Most preferably -J is moiety of formula (4′):
    -L-Q-T  (4′).
  • The alkanethiols and disulfides of the present invention may be synthesized using reagents and reaction well known to those of ordinary skill in the art, such as those described in “Advanced Organic Chemistry” J. March (Wiley & Sons, 1994); and “Organic Chemistry” 4th ed., Morrison and Boyd (Allyn and Bacon, Inc., 1983). For example, the following reaction scheme may be used:
    Figure US20050255582A1-20051117-C00007
  • Further photolysis with thioacetic acid and AIBN (2,2′-azobisisobutyronitrile) in THF (tetrahydrofuran) forms the thioester of the alkanethiol of formula (1). Hydrolysis then gives alkanethiols of formula (1) with -Q- being —O—. Optionally, —OH groups in -T may be protected using acetone, and deprotection may take place before, after, or during hydrolysis of the thioester. For alkanethiols of formula (1) where -Q- is —NH—, Br in the above reaction scheme above may be replaced with NH2, and the OH may be converted to a tosylate or mesylate. For alkanethiols of formula (1) where -Q- is —CH2—, the OH may be converted to a tosylate or mesylate, and Br converted to the corresponding Grignard. For alkanethiols of formula (1) where -Q- is —CO—O—, Br in the above reaction scheme may be replaced with CO2H. For alkanethiols of formula (1) where -Q- is —O—CO—, Br in the above reaction scheme may be replaced with OH, and the OH may be converted to the corresponding acid. For alkanethiols of formula (1) where -Q- is —NH—CO—, Br in the above reaction scheme may be replaced with NH2, and the OH may be converted to the corresponding acid. For alkanethiols of formula (1) where -Q- is —CO—NH—, Br in the above reaction scheme may be replaced with CO2H, and the OH may be converted to the corresponding primary amine (for example, by tosylation or mesylation followed by reaction with ammonia). For alkanethiols of formula (1) where -Q- is —NH—CO—NH—, Br in the above reaction scheme may be replaced with NH2, and the OH may be converted to the corresponding isocyanate. For alkanethiols of formula (1) where -Q- is —NH—CO—O—, Br in the above reaction scheme may be replaced with —N═C═O to give an isocyanate, which is then reacted with the hydroxyl as shown. Similarly, the disulfides may be formed by first forming alkanethiols, followed by oxidative coupling. When the disulfide is not symmetric, two different alkanethiols are oxidized together.
  • When applied to a surface containing gold, the alkanethiols and disulfides will form SAMs. In the case of the alkanethiols, the hydrogen is lost, and the remaining moiety attaches to the surface through the sulfur atom. In the case of the disulfides, the disulfide bridge is broken, and the remaining moieties attach to the surface through the sulfur atoms. The surface preferably has a plurality of alkanethiolate moieties shown in formula (5)
    Surf-S-L-Q-T  (5)
    where -L-, -Q- and -T have the same meaning as in formula (1), and Surf designates where the moiety attaches to the surface. The density of moieties on the surface is typically 1010±5% per square centimeter. The moieties of the present invention may cover the entire surface, or may be patterned on the surface. Patterning may be carried out by, for example, by microprinting, as described in Mrksich, M.; Dike, L. E.; Tien, J.; Ingber, D. E.; Whitesides, G. M., Experimental Cell Research 1997 235, 305-313; Chen, C. S.; Mrksich, M.; Huang, S.; Whitesides, G. M.; Ingber, D. E., Science 1997, 276, 1425-1428; and Mrksich, M.; Whitesides, G. M., TIBTECH. 1995, 13, 228-235.
  • Preferably the surface contains gold, more preferably the surface contains 50 to 100 atom percent gold. Preferably, the surface is pure or fine gold, or an alloy of gold with copper, silver, or a combination thereof.
  • The surface may be on a base. The base may have the same composition as the surface (for example a gold surface on a gold plate), or the surface may be, for example, a film, foil, sheet, or plate, on a base having a different composition. The base may be any material, such as metal, ceramic, plastic, or a natural material such as wood. Examples of bases include glass, quartz, silicon, transparent plastic, aluminum, carbon, polyethylene and polypropylene.
  • The surface material may be attached to the base by any of a variety of methods. For example, a film of the surface material may be applied to the base by sputtering or evaporation. If the surface material is a foil or sheet, in could be attached with an adhesive. Furthermore, the surface need not completely cover the base, but may cover only a portion of the base, or may form a pattern on the base. For example, portions of the base could be patterned by sputtering the base, covering those portions of the base where no surface material is desired. These patterns may include an array of regions containing, or missing, the surface material.
  • A cell chip is an array of regions containing cells on a surface, separated by regions containing no cells or cells at a much lower density. Since the SAMs of the present invention are inert, it is difficult for cells to attach. A cell chip may be prepared by applying SAMs of the present invention on regions of the surface that are to remain free of cells (or is intended to have cells at a lower density). The remaining regions could be left uncovered, or could be cover with SAMs that are not inert. For example, FIG. 3 illustrates one possible pattern, where circles 10 contain a SAM of hexadecanethiolate, and the remainder 20 of the surface is covered with a SAM of the present invention, all on a surface 2. Another example, FIG. 4 illustrates another possible pattern, where squares 30 contain a SAM of hexadecanethiolate, and regions 40 surrounding the squares contain a SAM of the present invention, all on a surface 2.
  • Once the surface is patterned as desired, the cells may be allowed to attach and proliferate in the regions not containing SAMs of the present invention, by contacting those regions with cells, and providing the nutrients and conditions necessary for the cells to proliferate.
  • One measure of the inertness of a surface is the number of day needed to fail a cell pattern test. A cell pattern test is carried out as follows: A surface is patterned into hydrophobic regions of hexadecanethiolate (HDT) and surrounded by the inert monolayer to be tested. The pattern is formed by microprinting. Albino 3T3-Swiss fibroblasts (American Type Culture Collection) are harvested from culture dishes with trypsin-EDTA, washed, and resuspended in DMEM (Dulbecco's Modification of Eagle's Medium) supplemented with 10% fetal bovine serum. The suspended cells are added to wells (10,000/well) containing patterned surfaces immersed in DMEM supplemented with serum. Serum-supplemented medium is exchanged with fresh medium after 12 hours and then every 5 days. Cell cultures are maintained at 37° C. and photographed daily. When the density of the cells in the test region is equal to or great than the density in the regions of hexadecanethiolate, the test is failed. Preferably, SAMs of the present invention do not fail the cell patterning test at 12 days, more preferably at 14 days, even more preferably at 25 days.
  • A protein chip is an array of regions containing protein, separated by regions containing no protein or protein at a much lower density. Since the SAMs of the present invention are inert, it is difficult for proteins to attach. In the same manner as a cell chip may be prepared, a protein chip may be prepared by applying SAMs of the present invention on regions of the surface that are to remain free of protein (or intended to have protein at a lower density). The remaining regions could be left uncovered, or could be cover with SAMs that are not inert. The same variety of patterns is possible with protein chips as described above for cell chips; FIGS. 3 and 4 are two possible patterns. The protein chip may then be prepared by contacting the surface with the desired protein or proteins.
  • Alternatively, a protein chip may be formed by covering both regions of the surface that are intended to have protein, and those that are not intended to have protein, with SAMs of the present invention. Those regions that are intended to have protein will also include an alkanethiolate corresponding to an alkanethiol terminated in a specific moiety. The protein to be attached is chosen to include a region that will capture the specific moiety, anchoring the protein to the chosen regions. For example, the specific moiety may be the conjugate of glutathione and benzoquinone of formula (6)
    Figure US20050255582A1-20051117-C00008

    and the protein may be a fusion protein of a protein of interest (such as the peptide hemagglutinin (HA) and glutathione S-transferase (GST) (the fusion protein being designated as GST-HA). When this fusion protein encounters the alkanethiolate terminating in the conjugate, the protein is cross-linked to the alkanethiolate, anchoring the protein in place. Since the SAM mostly contains the inert moiety of the present invention, other undesired proteins do not attach to the surface.
  • GST is commonly used as an affinity handle for the purification of recombinant proteins; the protein is expressed and purified as the GST fusion protein, and then treated with a protease to remove the GST domain (see, for example, Smith, D. B.; Johnson, K. S. Gene 1988, 67, 31). These fusion proteins could be used without synthetic modification to form protein chips. An additional benefit of using GST fusion proteins together with SAMs formed from alkanethiols terminated with the conjugate of formula (6) is that the reactivity of the surface towards immobilization could be controlled electrochemically, by way of reversible reduction of the quinone of formula (6) to the unreactive hydroquinone.
  • EXAMPLES
  • Two experimental procedures were used to evaluate the monolayers as inert surfaces. Surface plasmon resonance (SPR) spectroscopy measures the adsorption of protein to the monolayer. All SPR experiments were performed on a BIAcore 1000 instrument. Substrates were glued into plastic BIACore cassettes with a two-part epoxy (DEVCON). Phosphate-buffered saline (PBS; 10 mM phosphate, 150 mM sodium chloride, pH 7.6) was degassed under vacuum and all protein solutions were filtered through 0.45-μm filters before use. SPR is well suited for characterization of protein adsorption because it measures adsorption in situ and can detect weak, readily reversible protein adsorption. For all monolayers, a panel of five proteins that spanned a range in molecular weight and pI were investigated.
  • In a second set of experiments, the ability of the monolayers to pattern the long-term adhesion of albino Swiss 3T3 fibroblast cells was investigated. These experiments used monolayers that are patterned into hydrophobic regions of hexadecanethiolate (HDT) and surrounded by the inert monolayer. Cells initially attach only to the hydrophobic regions and proliferate to completely fill those regions after 2-3 days in culture. The periods of time that the cells remain confined to the pattern were compared—because the surrounding monolayer prevents attachment—to assess the effectiveness of the inert monolayer. The cell patterning experiments impose a more demanding environment than do the protein adsorption experiments, and hence, provide a more stringent test of inertness.
  • Protein adsorption and cell attachment on four different monolayers was compared. Gold films were prepared by evaporation of titanium (1.5 nm) and then gold (40 nm) onto glass cover slips (0.20 mm, No. 2, Corning). The SAMs were prepared by immersing gold films of approximately 1 cm2 in ethanolic solutions of alkanethiol (2 mM) for 9 hours. The SAMs were rinsed with ethanol and dried with nitrogen before use. As a control monolayer that is not inert, a SAM of hexadecanethiolate that presents hydrophobic methyl groups at the surface were used. Monolayers terminated in the tri(ethylene glycol) group were used as the current standard for inert surfaces. Each of the two additional monolayers presents the mannitol group and differs only in the length of alkyl chain to which the mannitol group is appended.
    Figure US20050255582A1-20051117-C00009
  • Alkanethiol 1a has an alkyl chain of eleven methylene units, which is the standard length in SAMs that are used in bio-interfacial science. Alkanethiol 1b has three fewer methylene units in the alkyl chain. Alkanethiol 2 terminates in the tri(ethylene glycol) group.
  • The synthetic scheme for preparing 1a and 1b is shown below. The following conditions were employed in the synthesis: (a) NaH/DMF; (b) CH3COSH, AlBN, hv, THF; (c) HCl/CH3OH, reflux. The reactions all used distilled solvents and were performed under a nitrogen atmosphere.
    Figure US20050255582A1-20051117-C00010
  • Dimethylketal 3. To a solution of 1,2:3,4-di-o-isopropylidene-D-mannitol (316 mg, 1.20 mmol) in DMF (10 ml) was added sodium hydride (30 mg, 60% dispersion in oil, 1.20 mmol). The solution was stirred for 10 min at room temperature and then 8-bromo-1-octene (220 mg, 1.20 mmol) was added over a period of 5 min. The solution was stirred for 12 hours and then concentrated in vacuo. The residue was purified by flash chromatography (1.5% CH3OH/CH2Cl2) to give 330 mg (0.883 mmol, 73%) of 3 as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 5.82-5.72 (m, 1H), 4.92 (q, J=10.2, 2H), 4.41-4.30 (m, 2H), 4.12-3.95 (m, 3H), 3.77-3.65 (m, 2H), 3.13 (d, J=6.16, 1H), 2.00 (q, J=7.1, 2H), 1.53 (s, 3H), 1.42 (s, 3H), 1.40 (s, 3H), 1.37 (s, 3H), 1.18 (m, 6H).
  • Thioester 4. A solution of 2 (151 mg, 0.41 mmol), thiol acetic acid (91 mg, 1.2 mmol) and AIBN (80 mg, 0.487 mmol) in THF (15 ml) was irradiated with UV light (RAYONET PHOTOCHEMICAL REACTOR LAMP) in a photochemical reactor for 5 hours with stirring. The solution was concentrated in vacuo and the residue was purified by flash chromatography (1% CH3OH/CH2Cl2) to give 147 mg (0.328 mmol, 82%) of 4 as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 4.41-4.30 (m, 2H), 4.12-3.95 (m, 3H), 3.77-3.65 (m, 2H), 3.57-3.47 (m, 3H), 3.14-3.12 (d, J=6.16, 1H), 2.90-2.85 (t, J=7.38, 2H), 2.33 (s, 3H), 1.64-1.55 (m, 4H), 1.53 (s, 3H), 1.42 (s, 3H), 1.40 (s, 3H), 1.37 (s, 3H), 1.41 (m, 6H).
  • Alkanethiol 1b. To a solution of 4 (147 mg, 0.328 mmol) in methanol (15 ml) was added 5 drops of 12 N HCl. The solution was refluxed for 8 hours, cooled, and concentrated in vacuo. The residue was purified by recrystallization from methanol to give 61 mg (0.187 mmol, 57%) of 1b as a white solid: 1H NMR (400 MHz, CD3OD) δ 3.85-3.59 (m, 6H), 3.58-3.46 (m, 4H), 2.52-2.45 (t, 2H), 1.64-1.55 (m, 4H), 1.45-1.28 (m, 8H).
  • Alkanethiol 1a. The mannitol-terminated alkanethiol 1a was synthesized with the same protocol starting with 1′-bromo-1-undecene in place of 8-bromo-1-octene.
  • SPR was used to measure the adsorption of five proteins—fibrinogen, pepsin, lysozyme, insulin, and trypsin—to the four monolayers. SPR measures changes in the refractive index of a solution near the interface with a gold film by measuring changes in the angle (ΔΘm) at which p-polarized light reflected from the glass/gold interface has a minimum in intensity. SAMs were mounted in a flow cell and experiments were performed by first flowing a phosphate buffered saline (PBS) through the cell for 5 minutes, then a solution of protein in the same buffer (0.5 mg/ml) for 5 minutes, and then PBS for 5 minutes. The rise in ΔΘm upon introduction of the protein solution has two contributions. The first is due to the increase in refractive index of the solution caused by the dissolved protein—the “bulk effect”—and does not represent protein adsorption. The second contribution is due to the adsorption of protein to the SAM. The amount of protein that adsorbs irreversibly to the SAM is determined by comparing the shift in Θm before and after the SAM is exposed to protein. An increase in Θm of 0.1° corresponds to an increase in density of adsorbed protein of 1 ng/mm2.
  • FIG. 1 shows data for the adsorption of fibrinogen to the four SAMs. A complete monolayer of protein adsorbs to the SAM of hexadecanethiolate. The change in Θm of 0.35° corresponds to a density of protein of 3,500 pg/mm2. The two monolayers presenting mannitol groups, by contrast, show essentially no adsorption of fibrinogen. This lack of adsorption is indistinguishable from that on monolayers presenting tri(ethylene glycol) groups. Experiments with the four other proteins gave similar results and demonstrated that the mannitol group is broadly effective at preventing protein adsorption, as shown in Table 1. For all five proteins, the amount of irreversible adsorption was less than 2% of the total amount that adsorbed on the methyl-terminated SAMs (HDT).
    TABLE 1
    Adsorption of Protein on Monolayers.
    Fibrinogenb Pepsin Lysozyme Insulin Trypsin
    Thick- 340 kD,d 35 kD, 14 kD, 5.4 kD, 24 kD,
    SAM nessa 5.5e <1 1.4 5.4 10.5
    1a 18.0 Å 27c <10 19 15 <10
    1b 15.7 Å 45 12 10 25 16
    2 19.5 Å 29 <10 <10 <10 <10
    HDT 20.0 Å 3,432 1,337 1,023 688 661

    aThickness of the SAM measured by ellipsometry (±0.5 Å).

    bAll protein solutions were 0.5 mg/ml in PBS (10 mM phosphate, 150 mM sodium chloride, pH = 7.6).

    cThe amount of protein that remains adsorbed to the SAM was determined by SPR and is reported in the units of pg/mm2. Each value of absorbed protein was taken from a single experiement and have a varience of approximately 5% across independent experiments.

    dMolecular weight of the protein.

    ep/ of the protein.
  • The degree to which these monolayers could prevent the adhesion and growth of cells that were confined to a patterned substrate was evaluated. Gold films were patterned by microcontact printing a set of circular regions of hexadecanethiolate that were 200 μm in diameter and then the films were immersed in a solution of 1a, 1b or 2 to assemble an inert monolayer on the non-printed areas. Albino 3T3-Swiss fibroblasts (American Type Culture Collection) were harvested from culture dishes with trypsin-EDTA, washed, and resuspended in DMEM supplemented with 10% fetal bovine serum. The suspended cells were added to wells (10,000/well) containing patterned substrates immersed in DMEM supplemented with serum. Serum-supplemented medium was exchanged with fresh medium after 12 hours and then every 5 days. Cell cultures were maintained at 37° C. and photographed daily. When the suspension of cells was added to culture wells containing the substrates, cells attached only to the methyl-terminated regions. For each of the substrates patterned with the inert monolayers (1a, 1b and 2), cells spread and proliferated to completely occupy these regions but did not invade the surrounding inert regions. The period of time that cells remain confined to the patterned monolayers provides a relative measure of the effectiveness of inert surface chemistries, and a direct measure for identifying inert surfaces that are most effective for applications requiring long-term cell patterning.
  • Albino 3T3-Swiss fibroblast cells patterned on the monolayers were kept at 37° C. in serum-containing media for four weeks. The media was exchanged every five days and cells were photographed daily, as shown in FIG. 2. In all cases, cells remained patterned to the circular regions of hexadecanethiolate for at least six days in culture. The tri(ethylene glycol)-terminated (prepared from alkanethiol 2) monolayers began to fail after seven days, with cells spreading onto the inert regions. After 12 days, cells had migrated from the circular regions and divided to give a confluent monolayer of cells, with a complete loss of pattern. Monolayers terminated in the mannitol group (prepared from alkanethiol 1a) were substantially more effective at confining cells for longer periods. Even after 21 days, cells remained completely confined to the patterns. After 25 days in culture, the viability of the adherent cells decreased, and therefore prevented an assessment of the monolayer over longer periods of time. Monolayers that presented the mannitol group on the shorter polymethylene chain (prepared from alkanethiol 1b) were also more effective than monolayers presenting the tri(ethylene glycol) group, but were not as effective as monolayers of 1a. Monolayers of 1b generally failed at two weeks in culture. These long-term patterning experiments were repeated on three separate occasions with consistent results: monolayers of 2 fail at approximately one week, monolayers of 1b fail at approximately two weeks and monolayers of 1a are effective for at least three weeks.
  • The SAMs 1a and 1b are highly effective as inert surfaces. SPR showed that monolayers of 1a and 1b prevented the adsorption of several different proteins, including the “sticky” protein fibrinogen. In this respect, the monolayers were indistinguishable from monolayers presenting tri(ethylene glycol) groups, which are the current standard for inert model surfaces. When evaluated for the ability to maintain the patterned adhesion of cells, it was found that SAMs of 1a were superior to SAMs presenting tri(ethylene glycol) groups. In this and other work, it has been found that SAMs presenting tri(ethylene glycol) groups fail at approximately seven days in culture. The SAMs of the present invention, by contrast, maintained the pattern of adherent cells over as many as 25 days.
  • A reaction scheme to prepare an alkanethiol terminated in a moiety that will cross-link to a glutathione S-transferase fusion protein (alkanethiol (Z)) is described below. In the reaction scheme, hydroquinone was protected as the bis-tetrahydropyranyl ether, which was then deprotonated with tert-butyl lithium and alkylated with 1,4-dibromobutane. Separately, molecule (Y) was prepared by protecting the tri(ethylene glycol)-terminated alkanethiol as the tritylthioether. The free hydroxyl group of this molecule was alkylated with (X) to give the conjugate. Deprotection of the tetrahydropyranyl ethers with pyridinium para-toluene sulfate revealed the hydroquinone, which was then oxidized with ammonium cerium nitrate to give the corresponding benzoquinone. Michael addition of the cysteine thiol of glutathione to the quinone resulted in the final precursor, which was treated with trifluoroacetic acid to remove the trityl protecting group.
    Figure US20050255582A1-20051117-C00011
    Figure US20050255582A1-20051117-C00012
    Figure US20050255582A1-20051117-C00013
  • A monolayer was prepared from a mixture of alkanethiol (Z) and a alkanethiol 1a (in a ratio of 1:99). The surface was treated to oxidize the hydroquinone group of alkanethiol (Z) to the corresponding benzoquinone, either by applied electrical potentials (+500 mV for 1 minute), or by treatment with a chemical oxidant (for example, with a substituted quinone). Surface plasmon resonance (SPR) spectroscopy was used to characterize the immobilization of GST-HA fusion protein to this monolayer. We used GST-HA as a model system because an antibody against this peptide is available. In these experiments, phosphate buffered saline (pH 7.4) was flowed over the monolayer for 2 minutes to establish a baseline. A solution of GST-HA (100 □M) in the same buffer was then flowed over the monolayer for 15 minutes to observe binding. Finally the protein solution was replaced with buffer for 5 minutes to quantitate the amount of protein that was irreversibly immobilized. The GST-HA was efficiently immobilized to the monolayer and the anti-HA antibody bound to the immobilized peptide. This antibody did not bind, however, to monolayers to which only GST had been immobilized, demonstrating the biospecificity that is afforded with the inert SAMs of the present invention.
  • The SAMs of the present invention are significant because they extend the time course over which cells can be patterned in culture. This enhancement is important for several applications that use cells as functional components. A primary example is the use of genetically engineered cells for screening libraries of drug candidates. This and other applications require substrates that can maintain patterned cell populations with excellent fidelity and over long periods of time. Furthermore, the SAMs of the present invention are highly effective at preventing protein adsorption and extend the times over which cultured cells can be maintained in patterns.
  • Obviously, numerous modifications and variations of the present invention are possible in light of the above teachings. It is therefore to be understood that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described herein.

Claims (20)

1. An alkanethiol of formula (1) and the enantimomers of the alkanethiol of formula (1):

HS-L-Q-T  (1),
where -L- is -(Ax-By-Ez-D)w-;
each A, B, E and D are individually C(RARA′)—, —C(RBRB′)—, —C(RERE′)—, and —C(RDRD′)—, respectively;
each RA, RB, RE and RD are individually H, or any two of RA, RB, RE and RD together form a bond, or RA, RB, RE and RD together with the atoms to which they are bonded form a six-membered aromatic ring;
each RA′, RB′, RE′ and RD′ are individually H, or any two of RA′, RB′, RE′ and RD′ together form a bond, or RA′, RB′, RE′ and RD′ together with the atoms to which they are bonded form a six-membered aromatic ring;
each x, y and z are individually either 0 or 1;
w is 1 to 5;
-Q- is selected from the group consisting of
Figure US20050255582A1-20051117-C00014
-T is a moiety of formula (2)
Figure US20050255582A1-20051117-C00015
R1 and R2 are each individually selected from the group consisting of H and OH;
a is 0 to 3;
b is 0 to 3; and
Figure US20050255582A1-20051117-P00900
indicates that the chirality of the carbon atom to which it is attached is either R or S.
2. The alkanethiol of claim 1, where -T is a moiety of formula (2′)
Figure US20050255582A1-20051117-C00016
3. The alkanethiol of claim 2, where -Q- is —O— or —CH2— and
4. A disulfide of formula (3) and the enantimomers of the disulfide of formula (3):

T-Q-L-S—S-J  (3),
where -L- is -(Ax-By-Ez-D)w-;
each A, B, E and D are individually C(RARA′)—, —C(RBRB′)—, —C(RERE′)—, and —C(RDRD′)—, respectively;
each RA, RB, RE and RD are individually H, or any two of RA, RB, RE and RD together form a bond, or RA, RB, RE and RD together with the atoms to which they are bonded form a six-membered aromatic ring;
each RA′, RB′, RE′ and RD′ are individually H, or any two of RA′, RB′, RE′ and RD′ together form a bond, or RA′, RB′, RE′ and RD′ together with the atoms to which they are bonded form a six-membered aromatic ring;
each x, y and z are individually either 0 or 1;
w is 1 to 5;
-Q- is selected from the group consisting of
Figure US20050255582A1-20051117-C00017
-T is a moiety of formula (2)
Figure US20050255582A1-20051117-C00018
R1 and R2 are each individually selected from the group consisting of H and OH;
a is 0 to 3;
b is 0 to 3;
Figure US20050255582A1-20051117-P00900
indicates that the chirality of the carbon atom to which it is attached is either R or S;
-J is selected from the group consisting of H, halogen, R, —OR, —NRR′, —C(O)R, and —C(O)OR;
R is selected from the group consisting of alkyl, alkenyl, alkynyl, aryl and heterocyclic radical; and
R′ is selected from the group consisting of H, alkyl, alkenyl, alkynyl, aryl and heterocyclic radical.
5. The disulfide of claim 4, where -J is a moiety of formula (4):

-L′-Q′-T′  (4),
an alkyl having 1 to 4 carbon atoms, or —(CH2)c(OCH2CH2)nOH; and
where -L′- is -(Ax-By-Ez-D)w-;
-Q′- is selected from the group consisting of
Figure US20050255582A1-20051117-C00019
-T′ is a moiety of formula (2)
Figure US20050255582A1-20051117-C00020
c is 2 to 20, and
n is 1 to 3.
6. The disulfide of claim 5, where -J is a moiety of formula (4′):

-L-Q-T  (4′).
7. The disulfide of claim 6, where -T is a moiety of formula (2′)
Figure US20050255582A1-20051117-C00021
8. The disulfide of claim 7, where -Q- is —O— or —CH2—.
9. A substrate, comprising:
(i) a surface layer comprising gold, and
(ii) a plurality of moieties, on at least a portion of the surface layer,
where the moieties are alkanethiolate moieties of formula (5) and enantimomers of the alkanethiolate moieties of formula (5):

Surf-S-L-Q-T  (5);
-L- is -(Ax-By-Ez-D)w-;
each A, B, E and D are individually C(RARA′)—, —C(RBRB′)—, —C(RERE′)—, and —C(RDRD′)—, respectively;
each RA, RB, RE and RD are individually H, or any two of RA, RB, RE and RD together form a bond, or RA, RB, RE and RD together with the atoms to which they are bonded form a six-membered aromatic ring;
each RA′, RB′, RE′ and RD′ are individually H, or any two of RA′, RB′, RE′ and RD′ together form a bond, or RA′, RB′, RE′ and RD′ together with the atoms to which they are bonded form a six-membered aromatic ring;
each x, y and z are individually either 0 or 1;
w is 1 to 5;
-Q- is selected from the group consisting of
Figure US20050255582A1-20051117-C00022
-T is a moiety of formula (2)
Figure US20050255582A1-20051117-C00023
R1 and R2 are each individually selected from the group consisting of H and OH;
a is 0 to 3;
b is 0 to 3;
Figure US20050255582A1-20051117-P00900
indicates that the chirality of the carbon atom to which it is attached is either R or S; and
Surf designates where the moiety attaches to the surface.
10. The substrate of claim 9, further comprising:
(iii) a monolayer comprising the moieties,
where the monolayer does not fail a cell patterning test at 12 days.
11. The substrate of claim 9, further comprising:
(iv) a base,
where the surface layer is on the base.
12. The substrate of claim 11, where -T is a moiety of formula (2′)
Figure US20050255582A1-20051117-C00024
13. The substrate of claim 12, where -Q- is —O— or —CH2—.
14. The substrate of claim 9, where the monolayer does not fail a cell patterning test at 12 days.
15. A cell chip, comprising:
(A) the substrate of claim 9, and
(B) cells, on the substrate.
16. A method of making the alkanethiol of claim 1, comprising:
hydrolyzing a thioester, to form the alkanethiol of formula (1).
17. A method of making the disulfide of claim 4, comprising:
oxidizing a first alkanethiol, to form the disulfide of formula (3).
18. A method of making a substrate, comprising contacting a surface with the alkanethiol of claim 1;
where the surface comprises gold.
19. A method of making a substrate, comprising contacting a surface with the disulfide of claim 4;
where the surface comprises gold.
20. A method of making a cell chip, comprising:
contacting cells with the substrate of claim 9.
US11/124,022 2000-10-11 2005-05-06 Surface modifying composition Abandoned US20050255582A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/124,022 US20050255582A1 (en) 2000-10-11 2005-05-06 Surface modifying composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/689,263 US6972196B1 (en) 2000-10-11 2000-10-11 Making surfaces inert by modifying with alkanethiolates
US11/124,022 US20050255582A1 (en) 2000-10-11 2005-05-06 Surface modifying composition

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/689,263 Continuation US6972196B1 (en) 2000-10-11 2000-10-11 Making surfaces inert by modifying with alkanethiolates

Publications (1)

Publication Number Publication Date
US20050255582A1 true US20050255582A1 (en) 2005-11-17

Family

ID=24767702

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/689,263 Expired - Fee Related US6972196B1 (en) 2000-10-11 2000-10-11 Making surfaces inert by modifying with alkanethiolates
US11/124,022 Abandoned US20050255582A1 (en) 2000-10-11 2005-05-06 Surface modifying composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/689,263 Expired - Fee Related US6972196B1 (en) 2000-10-11 2000-10-11 Making surfaces inert by modifying with alkanethiolates

Country Status (3)

Country Link
US (2) US6972196B1 (en)
AU (1) AU2002211741A1 (en)
WO (1) WO2002030885A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060172881A1 (en) * 2004-12-22 2006-08-03 Devaraj Neal K Method of spatially controlling catalysis of a chemical reaction
US20080064606A1 (en) * 2001-08-07 2008-03-13 The University Of Chicago Polypeptide immobilization

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393656B2 (en) * 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
EP1521961A2 (en) * 2002-07-05 2005-04-13 The University of Chicago Characterization of biochips containing self-assembled monolayers with maldi-tof-ms
US7759677B2 (en) * 2006-09-05 2010-07-20 Electronics And Telecommunications Research Institute Molecular electronic device including organic dielectric thin film and method of fabricating the same
US8642516B2 (en) * 2012-05-07 2014-02-04 Wisconsin Alumni Research Foundation Chemically-defined arrays for screening cell-substrate interactions

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461304A (en) * 1979-11-05 1984-07-24 Massachusetts Institute Of Technology Microelectrode and assembly for parallel recording of neurol groups
US5254235A (en) * 1992-02-26 1993-10-19 The Yellow Springs Instrument Company Microelectrode arrays
US5286944A (en) * 1992-03-25 1994-02-15 Panasonic Technologies, Inc. Method of manufacturing a multiple microelectrode assembly
US5524338A (en) * 1991-10-22 1996-06-11 Pi Medical Corporation Method of making implantable microelectrode
US5744627A (en) * 1994-01-28 1998-04-28 Prolinx, Inc. Boronic compound complexing reagents and complexes
US5804048A (en) * 1996-08-15 1998-09-08 Via Medical Corporation Electrode assembly for assaying glucose
US20030119054A1 (en) * 2001-08-07 2003-06-26 Milan Mrksich Polypeptide immobilization
US6784768B1 (en) * 2003-04-09 2004-08-31 M/A - Com, Inc. Method and apparatus for coupling energy to/from dielectric resonators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6261965A (en) 1985-09-11 1987-03-18 Kao Corp Bis(2-gluconamidoalkyl)disulfide
JPH06192058A (en) 1992-12-24 1994-07-12 Kao Corp Hair remover composition

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461304A (en) * 1979-11-05 1984-07-24 Massachusetts Institute Of Technology Microelectrode and assembly for parallel recording of neurol groups
US5524338A (en) * 1991-10-22 1996-06-11 Pi Medical Corporation Method of making implantable microelectrode
US5254235A (en) * 1992-02-26 1993-10-19 The Yellow Springs Instrument Company Microelectrode arrays
US5286944A (en) * 1992-03-25 1994-02-15 Panasonic Technologies, Inc. Method of manufacturing a multiple microelectrode assembly
US5744627A (en) * 1994-01-28 1998-04-28 Prolinx, Inc. Boronic compound complexing reagents and complexes
US5804048A (en) * 1996-08-15 1998-09-08 Via Medical Corporation Electrode assembly for assaying glucose
US20030119054A1 (en) * 2001-08-07 2003-06-26 Milan Mrksich Polypeptide immobilization
US6784768B1 (en) * 2003-04-09 2004-08-31 M/A - Com, Inc. Method and apparatus for coupling energy to/from dielectric resonators

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080064606A1 (en) * 2001-08-07 2008-03-13 The University Of Chicago Polypeptide immobilization
US7888055B2 (en) 2001-08-07 2011-02-15 The University Of Chicago Polypeptide immobilization
US9074300B2 (en) 2001-08-07 2015-07-07 The University Of Chicago Polypeptide immobilization
US20060172881A1 (en) * 2004-12-22 2006-08-03 Devaraj Neal K Method of spatially controlling catalysis of a chemical reaction

Also Published As

Publication number Publication date
AU2002211741A1 (en) 2002-04-22
WO2002030885A2 (en) 2002-04-18
US6972196B1 (en) 2005-12-06
WO2002030885A3 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
US20050255582A1 (en) Surface modifying composition
Feldman et al. Probing resistance to protein adsorption of oligo (ethylene glycol)-terminated self-assembled monolayers by scanning force microscopy
Lahiri et al. Biospecific binding of carbonic anhydrase to mixed SAMs presenting benzenesulfonamide ligands: a model system for studying lateral steric effects
Xia et al. Functionalized poly (ethylene glycol)-grafted polysiloxane monolayers for control of protein binding
Mrksich et al. Using self-assembled monolayers to understand the interactions of man-made surfaces with proteins and cells
Dillmore et al. A photochemical method for patterning the immobilization of ligands and cells to self-assembled monolayers
Houseman et al. The microenvironment of immobilized Arg-Gly-Asp peptides is an important determinant of cell adhesion
US6821529B2 (en) Oligo(ethylene glycoll)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
Zhou et al. AFM study on protein immobilization on charged surfaces at the nanoscale: toward the fabrication of three-dimensional protein nanostructures
Li et al. Ultralow fouling zwitterionic polymers grafted from surfaces covered with an initiator via an adhesive mussel mimetic linkage
Hobara et al. Surface structure of binary self-assembled monolayers formed by electrochemical selective replacement of adsorbed thiols
US7351838B2 (en) N-sulfonyldicarboximide containing tethering compounds
Persson et al. Versatile method for chemical reactions with self-assembled monolayers of alkanethiols on gold
De Bartolo et al. Biotransformation and liver-specific functions of human hepatocytes in culture on RGD-immobilized plasma-processed membranes
US6764768B2 (en) Controlled release composition
CN104094119A (en) Functionalized nanoparticles for intracellular delivery of biologically active molecules
US6756354B2 (en) Therapeutic compositions containing oligo (ethylene glycol)-terminated 1,2-dithiolanes and their conjugates
Chan et al. A photo-electroactive surface strategy for immobilizing ligands in patterns and gradients for studies of cell polarization
Lee et al. Multifunctional and stable monolayers on carbon: a simple and reliable method for backfilling sparse layers grafted from protected aryldiazonium ions
Cotton et al. Dynamics of the formation of mixed alkanethiol monolayers: Applications in structuring biointerfacial arrangements
EP1316800B1 (en) Gelatine based substrate for protein-biochips
Iqbal et al. Surface molecular tailoring using pH-switchable supramolecular dendron-ligand assemblies
EP0214089B1 (en) A photo-hardenable composition for bioactive coatings
Lee et al. Enzyme-modified Langmuir-Blodgett membranes in glucose electrodes based on avidin-biotin interaction
Vikholm-Lundin et al. Cysteine-tagged chimeric avidin forms high binding capacity layers directly on gold

Legal Events

Date Code Title Description
AS Assignment

Owner name: THE UNIVERSITY OF CHICAGO, ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MRKSICH, MILAN;LUK, YAN-YEUNG;REEL/FRAME:016320/0848

Effective date: 20050725

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF

Free format text: CONFIRMATORY LICENSE;ASSIGNOR:UNIVERSITY OF CHICAGO;REEL/FRAME:021298/0204

Effective date: 20051218